Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-05 Sale |
2023-01-09 6:18 pm |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
212,500 | $108.74 | $23,106,230 | 13,622 (Direct) |
View |
| 2021-11-26 Purchase |
2021-11-29 4:48 pm |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
4,974 | $102.44 | $509,539 | 13,276 (Direct) |
View |
| 2021-04-13 Sale |
2021-04-15 6:01 pm |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
97,973 | $196.34 | $19,236,323 | 8,184 (Direct) |
View |
| 2020-12-18 Sale |
2020-12-22 6:37 pm |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
207,910 | $157.39 | $32,722,764 | 301,587 (Direct) |
View |
| 2020-09-15 Sale |
2020-09-17 4:32 pm |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
103,000 | $99 | $10,197,000 | 405,542 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-01 Option Award |
2025-01-03 4:04 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Director |
400,000 | $0 | 415,640 (Direct) |
View |
| 2024-12-31 Option Award |
2025-01-03 4:04 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Director |
412 | $14.75 | 415,640 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-06 4:19 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
1,239 | $12.24 | 15,228 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-06 4:12 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
367 | $35.28 | 13,989 (Direct) |
View |
| 2023-01-06 Option Award |
2023-01-09 6:18 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
39 | $62.3 | 13,622 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-09 6:18 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
25,000 | $11.46 | 13,622 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-09 6:18 pm |
N/A 2026-02-24 |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
212,500 | $0 | 13,622 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-09 6:18 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
187,500 | $7.15 | 13,622 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-07 5:48 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
276 | $59.08 | 13,583 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:22 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
13,470 | $80.59 | 13,470 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-12 5:31 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
31 | $63.82 | 13,307 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:31 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
118 | $137.12 | 8,302 (Direct) |
View |
| 2021-02-27 Exercise |
2021-03-02 4:17 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
9,259 | $149.1 | 206,944 (Direct) |
View |
| 2021-02-27 Exercise |
2021-03-02 4:17 pm |
2021-02-27 N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
9,259 | $0 | 206,944 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 4:30 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
53 | $50.67 | 197,685 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-22 6:37 pm |
N/A 2025-10-01 |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
207,910 | $0 | 301,587 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-22 6:37 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
103,955 | $22 | 301,587 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-17 4:32 pm |
N/A 2025-10-01 |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
103,000 | $0 | 405,542 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-17 4:32 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
103,000 | $22 | 405,542 (Direct) |
View |
| 2020-07-07 Option Award |
2020-07-08 4:18 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
284 | $50.41 | 197,632 (Direct) |
View |